patent expiration

Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent expiration for Gilead Sciences drug ATRIPLA appeared fi…

Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are eleven…
The post New patent expiration for Gilead Sciences drug STRIBILD appeared fi…

Annual Drug Patent Expirations for WINLEVI Winlevi is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Sun Pharm drug WINLEVI appeared first on DrugP…

Annual Drug Patent Expirations for TOBI+PODHALER Tobi Podhaler is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Mylan Speciality drug TOBI PODHALER ap…

TOBI PODHALER (tobramycin) Mylan speciality lp Patent: 7,516,741 Expiration: Jan 11, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations fo…

Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on D…

Annual Drug Patent Expirations for TASIGNA Tasigna is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Novartis drug TASIGNA appeared first…

TASIGNA (nilotinib hydrochloride) Novartis Patent: 7,169,791 Expiration: Jan 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…

Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seventeen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared firs…

Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared fi…